EcoDrugPlus

Estrogen Receptor Beta

Ensembl ID : ENSFHEG00000015962
Gene Symbol: LOC105935418
3 Cross references
200 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSFHEG00000011692
Gene Symbol: LOC105935507
3 Cross references
207 Possible Orthologues:

Estrogen-Related Receptor Gamma

Ensembl ID : ENSFHEG00000019626
Gene Symbol: LOC105939401
3 Cross references
203 Possible Orthologues:

Exportin 1

Ensembl ID : ENSFHEG00000018974
Gene Symbol: XPO1
1 Cross references
218 Possible Orthologues:

Exportin 1

Ensembl ID : ENSFHEG00000002412
Gene Symbol: XPO1
3 Cross references
229 Possible Orthologues:

Farnesyl Pyrophosphate Synthase

Ensembl ID : ENSFHEG00000021384
Gene Symbol: LOC105928432
3 Cross references
268 Possible Orthologues:

Farnesyl Pyrophosphate Synthase-Like

Ensembl ID : ENSFHEG00000021296
Gene Symbol: LOC105928434
3 Cross references
262 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSFHEG00000001212
Gene Symbol: FDFT1
3 Cross references
221 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSFHEG00000016727
Gene Symbol: FNTA
3 Cross references
222 Possible Orthologues:

Female Protein-Like

Ensembl ID : ENSFHEG00000015001
Gene Symbol: LOC105929710
2 Cross references
391 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSFHEG00000011699
Gene Symbol: FGFR1
3 Cross references
201 Possible Orthologues:

Fibroblast Growth Factor Receptor 1-A-Like

Ensembl ID : ENSFHEG00000001221
Gene Symbol: LOC105928781
4 Cross references
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).